Intended for healthcare professionals

  1. Secondary prevention...
  2. Secondary prevention of vascular disease by prolonged antiplatelet treatment
Clinical Research

Secondary prevention of vascular disease by prolonged antiplatelet treatment

Br Med J (Clin Res Ed) 1988; 296 doi: https://doi.org/10.1136/bmj.296.6618.320 (Published 30 January 1988) Cite this as: Br Med J (Clin Res Ed) 1988;296:320

Related articles

See more

Cited by...

  • A Comparison of Contemporary versus Older Studies of Aspirin for Primary Prevention
  • From Early Pharmacology to Recent Pharmacology Interventions in Acute Coronary Syndromes: JACC State-of-the-Art Review
  • NICE and new: appraising innovation
  • Personal Reflections From a Front-Row Seat at the Greatest Show on Earth (Life): Part II (Stroke Research Commentary)
  • Long term survival after evidence based treatment of acute myocardial infarction and revascularisation: follow-up of population based Perth MONICA cohort, 1984-2005
  • Cardiovascular Outcomes in the Outpatient Kidney Transplant Clinic: The Framingham Risk Score Revisited
  • Effects of a Novel Platelet Nitric Oxide Donor (LA816), Aspirin, Clopidogrel, and Combined Therapy in Inhibiting Flow- and Lesion-Dependent Thrombosis in the Porcine Ex Vivo Model
  • The Willis Lecture 2003: Evaluating Treatments for Stroke Patients Too Slowly: Time to Get Out of Second Gear
  • Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction
  • Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Risk of Hospitalization for Intracerebral Hemorrhage: A Population-Based Case-Control Study
  • Aspirin-associated intracerebral hemorrhage: Clinical and radiologic features
  • DOES LOW-DOSE ASPIRIN THERAPY COMPLICATE ORAL SURGICAL PROCEDURES?
  • Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile
  • Admissible evidence
  • Cost-Effectiveness of Tests to Assess the Risk of Sudden Death After Acute Myocardial Infarction
  • Leukocyte activation with platelet adhesion after coronary angioplasty: A mechanism for recurrent disease?
  • Marked reduction in long-term cardiac deaths with aspirin after a coronary event
  • Natural history of severe atheromatous disease of the thoracic aorta: A transesophageal echocardiographic study
  • Collaborative overview of randomised trials of antiplatelet therapy - II: Maintenance of vascular graft or arterial patency by antiplatelet therapy
  • Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
  • IPO-V2: A prospective, multicenter, randomized, comparative clinical investigation of the effects of sulodexide in preventing cardiovascular accidents in the first year after acute myocardial infarction
  • Aspirin to prevent heart attack or stroke
  • Toward the quiescent coronary plaque
  • Verapamil and aspirin modulate platelet-mediated vasomotion in arterial segments with intact or disrupted endothelium
  • Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris
  • Effects of aspirin in arterial thrombosis: Why don't animals behave the way humans do?
  • High dose intravenous aspirin, not low dose intravenous or oral aspirin, inhibits thrombus formation and stabilizes blood flow in experimental coronary vascular injury
  • Aspirin (75 mg/day) after an episode of unstable coronary artery disease: Long-term effects on the risk for myocardial infarction, occurrence of severe angina and the need for revascularization
  • The antiplatelet effects of organic nitrates and related nitroso compounds in vitro and in vivo and their relevance to cardiovascular disorders
  • Thrombolysis: The need for a critical review
  • Combined thromboxane A2synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations
  • How to Perform a Meta-Analysis
  • Guidelines for the early management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (subcommittee to develop guidelines for the early management of patients with acute myocardial infarction)
  • Platelet inhibitor agents in cardiovascular disease: An update
  • Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
Back to top